As mentioned in an earlier post; I DONT KNOW, but I'm sure they are not sitting on their hands.
Mount Sinai have been right across this from the get go in running the EAP and shutting it down to prepare for the real proof of treatment trial.
With an enrollment date of April 30th. I'm feeling more convinced that multiple patients have not only been dosed, but FULLY dosed by May 6th.
Whilst trial enrollment is still taking place in a number of centres I feel that there is a sizable patient cohort (maybe not 90) that are very well advanced with the treatment. Is it just me or do others feel more confidence in the tone of the language that is beginning to filter through.
June 5th marks the 30 day trial primary data readout date for what I think will be a sizeable patient cohort; maybe not the required 90 to prompt an official announcement, but sufficient to provide a strong indicator. Can this early data be kept under wraps? I DONT KNOW.
Cell Therapy News/Articles, page-2936
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |